Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haidbao is a marine biotechnology company based in Qingdao, China, focused on the research, development, and commercialization of marine-derived bioactive materials. The company's core technology centers on cationic antimicrobial peptides (CAPs) extracted from marine organisms, which serve as a non-antibiotic and non-hormonal alternative for treating skin and mucosal conditions. Haidbao's product portfolio includes medical devices and functional skincare products targeting atopic dermatitis, chronic wound healing, and gynecological health. By leveraging its proprietary marine peptide platform, the company addresses unmet needs in dermatology and infection control. Haidbao operates integrated R&D and manufacturing facilities that comply with medical-grade standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 海得宝.